These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 17353133)

  • 1. Synovial and plasma glucosamine concentrations in osteoarthritic patients following oral crystalline glucosamine sulphate at therapeutic dose.
    Persiani S; Rotini R; Trisolino G; Rovati LC; Locatelli M; Paganini D; Antonioli D; Roda A
    Osteoarthritis Cartilage; 2007 Jul; 15(7):764-72. PubMed ID: 17353133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucosamine oral bioavailability and plasma pharmacokinetics after increasing doses of crystalline glucosamine sulfate in man.
    Persiani S; Roda E; Rovati LC; Locatelli M; Giacovelli G; Roda A
    Osteoarthritis Cartilage; 2005 Dec; 13(12):1041-9. PubMed ID: 16168682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of pharmacokinetics of glucosamine and synovial fluid levels following administration of glucosamine sulphate or glucosamine hydrochloride.
    Meulyzer M; Vachon P; Beaudry F; Vinardell T; Richard H; Beauchamp G; Laverty S
    Osteoarthritis Cartilage; 2008 Sep; 16(9):973-9. PubMed ID: 18295513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Joint inflammation increases glucosamine levels attained in synovial fluid following oral administration of glucosamine hydrochloride.
    Meulyzer M; Vachon P; Beaudry F; Vinardell T; Richard H; Beauchamp G; Laverty S
    Osteoarthritis Cartilage; 2009 Feb; 17(2):228-34. PubMed ID: 18692410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of lumiracoxib in plasma and synovial fluid.
    Scott G; Rordorf C; Reynolds C; Kalbag J; Looby M; Milosavljev S; Weaver M; Huff JP; Ruff DA
    Clin Pharmacokinet; 2004; 43(7):467-78. PubMed ID: 15139795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synovial fluid levels and serum pharmacokinetics in a large animal model following treatment with oral glucosamine at clinically relevant doses.
    Laverty S; Sandy JD; Celeste C; Vachon P; Marier JF; Plaas AH
    Arthritis Rheum; 2005 Jan; 52(1):181-91. PubMed ID: 15641100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and validation of a HPLC-ES-MS/MS method for the determination of glucosamine in human synovial fluid.
    Pastorini E; Rotini R; Guardigli M; Vecchiotti S; Persiani S; Trisolino G; Antonioli D; Rovati LC; Roda A
    J Pharm Biomed Anal; 2009 Dec; 50(5):1009-14. PubMed ID: 19647388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of an oral administration of glucosamine-chondroitin-quercetin glucoside on the synovial fluid properties in patients with osteoarthritis and rheumatoid arthritis.
    Matsuno H; Nakamura H; Katayama K; Hayashi S; Kano S; Yudoh K; Kiso Y
    Biosci Biotechnol Biochem; 2009 Feb; 73(2):288-92. PubMed ID: 19202302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Relative bioavailability of glucosamine after oral, intramuscular and transdermal administration of hondroxid maximum preparation in experiment].
    Yasso B; Li Y; Alexander A; Mel'nikova NB; Mukhina IV
    Eksp Klin Farmakol; 2014; 77(12):26-32. PubMed ID: 25739190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [6-methoxy-2-naphthylacetic acid level in plasma, synovial fluid and adjacent tissue in patients with rheumatoid arthritis or gonarthroses after a 4-day therapy with nabumetone (Arthaxan)].
    Miehlke RK; Schneider S; Sörgel F; Muth P; Henschke F; Fedder M
    Z Rheumatol; 1991; 50(2):103-8. PubMed ID: 1872041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low levels of human serum glucosamine after ingestion of glucosamine sulphate relative to capability for peripheral effectiveness.
    Biggee BA; Blinn CM; McAlindon TE; Nuite M; Silbert JE
    Ann Rheum Dis; 2006 Feb; 65(2):222-6. PubMed ID: 16079170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucosamine binding to proteins in plasma and synovial fluid and blood cell/plasma partitioning in mouse and man in vitro.
    Persiani S; Matthews A; Larger P; Hall M; Rotini R; Trisolino G; Antonioli D; Zaccarelli L; Rovati LC
    Drug Metabol Drug Interact; 2009; 24(2-4):211-27. PubMed ID: 20408501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synovial cytology of osteoarthrosis after intra-articular injection of glucosamine salts.
    Boonyaratavej N
    J Med Assoc Thai; 1977 Jan; 60(1):30-4. PubMed ID: 845528
    [No Abstract]   [Full Text] [Related]  

  • 14. [Therapy of osteoarthritis crystalline glucosamine sulphate/a review of the clinical effcacy].
    Heisel J; Förster KK
    Arzneimittelforschung; 2007; 57(4):203-17. PubMed ID: 17515291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single dose pharmacokinetics and bioavailability of glucosamine in the rat.
    Aghazadeh-Habashi A; Sattari S; Pasutto F; Jamali F
    J Pharm Pharm Sci; 2002; 5(2):181-4. PubMed ID: 12207871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transsynovial kinetics of lonazolac and its hydroxy metabolite in synovitis patients.
    Deneke J; Luckow V; Guserle R; Pässler HH
    Int J Clin Pharmacol Ther; 1998 Aug; 36(8):418-24. PubMed ID: 9726694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variation in Plasma Levels of Glucosamine With Chronic Dosing: A Possible Reason for Inconsistent Clinical Outcomes in Osteoarthritis.
    Asthana C; Peterson GM; Shastri MD; Jones G; Patel RP
    Clin Ther; 2020 Aug; 42(8):e140-e149. PubMed ID: 32713600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma and synovial fluid concentrations of nimesulide and its main metabolite after a single or repeated oral administration in patients with knee osteoarthritis.
    Bianchi M; Ferrario P; Balzarini P; Broggini M
    J Int Med Res; 2006; 34(4):348-54. PubMed ID: 16989489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sulfate could mediate the therapeutic effect of glucosamine sulfate.
    Hoffer LJ; Kaplan LN; Hamadeh MJ; Grigoriu AC; Baron M
    Metabolism; 2001 Jul; 50(7):767-70. PubMed ID: 11436179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Naproxen kinetics in synovial fluid of patients with osteoarthritis.
    Bruno R; Iliadis A; Jullien I; Guego M; Pinhas H; Cunci S; Cano JP
    Br J Clin Pharmacol; 1988 Jul; 26(1):41-4. PubMed ID: 3203059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.